SCHEMBL8001035

SCHEMBL8001035

COc1nc2ccccc2nc1-c1cccc(/C=C/Cc2nnc(C)o2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.34
HDAC1 Q13547 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
POLB P06746 1/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
LIPC P11150 2/20 0.31
LIPG Q9Y5X9 2/20 0.31
NPC1 O15118 1/20 0.31
NFKB1 P19838 1/20 0.31
RAB9A P51151 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PTK2 Q05397 1/20 0.31
PDE10A Q9Y233 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8000609 0.91 L3MBTL1 (0.33) L3MBTL1HDAC1HDAC8HDAC6POLB
SCHEMBL7998577 0.89 L3MBTL1 (0.32) L3MBTL1HDAC1HDAC8HDAC6POLB
SCHEMBL7998444 0.88 L3MBTL1 (0.32) L3MBTL1HDAC1HDAC8HDAC6LIPC
SCHEMBL8007633 0.87 LIPC (0.31) L3MBTL1HDAC1HDAC8HDAC6LIPC
SCHEMBL10292951 0.81 ALDH1A1 (0.34) KDM4EALDH1A1LMNANPC1RAB9A
SCHEMBL10292912 0.79 L3MBTL1 (0.32) L3MBTL1PTK2
SCHEMBL7998537 0.78 L3MBTL1 (0.34) L3MBTL1HDAC1HDAC8HDAC6POLB
SCHEMBL7998449 0.77 L3MBTL1 (0.38) L3MBTL1POLBKDM4EALDH1A1LMNA
SCHEMBL8008303 0.77 L3MBTL1 (0.38) L3MBTL1POLBKDM4EALDH1A1LMNA
SCHEMBL8007763 0.77 GRIN1 (0.35) HDAC1HDAC8HDAC6KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009134987-A1 DIFLUOROMETHYL-CONTAINING MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-11-05 WO disclosed